| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 4,6500% | ₹175.1 0% | 800 | ₹2 0% | 7750% |
| - | - | 840 | ₹2.25 0% | 7750% |
| 7750% | ₹131 0% | 850 | ₹2.25 -23.72% | 65,100-22.22% |
| - | - | 860 | - | - |
| - | - | 870 | ₹8.2 0% | 5,4250% |
| 1,5500% | ₹104.8 0% | 880 | ₹4.75 -16.66% | 53,47540.81% |
| - | - | 890 | ₹6.3 -53.67% | 20,150550% |
| 93,7750.83% | ₹76.05 -3.12% | 900 | ₹7.5 -9.63% | 1,59,65010.16% |
| - | - | 910 | ₹9.35 -60.12% | 17,0501000% |
| 16,2750% | ₹64 0% | 920 | ₹11.6 -6.82% | 66,6507.5% |
| 24,8000% | ₹58 0% | 930 | ₹20.35 0% | 1,5500% |
| 1,5500% | ₹50 0% | 940 | ₹17.55 -4.35% | 39,52524.39% |
| 99,2004.06% | ₹41.4 -5.47% | 950 | ₹21.6 -1.59% | 49,600156% |
| 2,20,100158.18% | ₹35.55 -10.22% | 960 | ₹25.8 -1.52% | 1,15,475101.35% |
| 1,44,9259.35% | ₹30.9 -8.71% | 970 | ₹30.65 -0.96% | 78,27531.16% |
| 1,16,2500.67% | ₹25.8 -11.94% | 980 | ₹35.25 -0.98% | 89,900213.51% |
| 51,92552.27% | ₹21.1 -14.91% | 990 | ₹41.2 -6.36% | 31,7754000% |
| 3,96,025-5.89% | ₹18 -14.69% | 1,000 | ₹47.3 2.04% | 1,47,2501.60% |
| 7750% | ₹29 0% | 1,010 | - | - |
| 60,450200% | ₹11.9 -18.77% | 1,020 | ₹60 0% | 6,9750% |
| 1,15,47569.31% | ₹7.8 -23.52% | 1,040 | - | - |
| 17,05022.22% | ₹6.3 -24.09% | 1,050 | - | - |
| 62,0008.10% | ₹5.25 -18.6% | 1,060 | - | - |
| 44,175137.5% | ₹3.35 -30.2% | 1,080 | - | - |
| 1,71,27518.81% | ₹2.35 -28.78% | 1,100 | ₹135 5.46% | 2,3250% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
